Senior investigator at Molecular Biomedical Imaging Laboratory says U.S. medical professionals are prepared to deal with Ebola

Dr. David Bluemke is the Lab Chief and Senior Investigator at the Molecular Biomedical Imaging Laboratory at the National Institutes of Health | Courtesy of the National Institutes of Health

A senior investigator at the Molecular Biomedical Imaging Laboratory on Tuesday said U.S. medical professionals are well prepared to deal with Ebola.

Lab Chief and Senior Investigator Dr.David Bluemke spends his days at the National Institute of Biomedical Imaging and Biomedical Engineering at the National Institutes of Health working on projects related to cardiovascular diseases and complications that arise. His focus on the heart and how heart disease forms can be detected and tracked give Bluemke an important perspective on how diseases can be tracked after they are detected.

When it comes to biological outbreaks and diseases like Ebola, he has a positive view of the preparation of how doctors and medical professionals have prepared for potential cases of Ebola infections, as well as the research efforts underway to learn more about the disease, its treatment and how to stop it altogether.

“Scientists and physicians have learned a tremendous amount about Ebola in the past three to four months,” Bluemke said in an interview with BioPrepWatch.com. “They are well prepared for this outbreak.”

In his work, Bluemke has been part of projects related to hospital preparedness for biological outbreaks, especially for diseases like Ebola.

“All major hospitals are working to screen patients who are at risk of infection with Ebola and to implement standard procedures that are documented to be effective in isolating patients who are at risk and to effectively treat those individuals,” Bluemke said.

Some of his other research and projects include evaluation of imaging methods to quantify myocardial fibrosis, where the muscles of the heart are hardened or scarred; use of genetic imaging to prevent hypertrophic cardiomyopathy and using advanced imaging to evaluate atherosclerotic plaque regression.

Organizations in this story

National Institutes of Health 9000 Rockville Pike Bethesda, MD 20892

Get notified the next time we write about National Institutes of Health!